APA (7th ed.) Citation

AR, G., C, P., MF, L., LA, B., KA, B., AE, R., . . . KJ, T. (2026). Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo Efficacy. ACS chemical neuroscience, 17(3), 649. https://doi.org/10.1021/acschemneuro.5c00963

Chicago Style (17th ed.) Citation

AR, Gregro, et al. "Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo Efficacy." ACS Chemical Neuroscience 17, no. 3 (2026): 649. https://doi.org/10.1021/acschemneuro.5c00963.

MLA (9th ed.) Citation

AR, Gregro, et al. "Discovery of VU6025733 (AG06827): A Highly Selective, Orally Bioavailable, and Structurally Distinct M4 Muscarinic Acetylcholine Receptor Positive Allosteric Modulator (PAM) with Robust In Vivo Efficacy." ACS Chemical Neuroscience, vol. 17, no. 3, 2026, p. 649, https://doi.org/10.1021/acschemneuro.5c00963.